Mailbag: Questions From You!
Description
In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright field questions from listeners. Throughout the show, our hosts highlight the importance of compassionate, science-based medical care and underscore the significance of finding healthcare providers who address metabolic issues as medical, not lifestyle, concerns.
Among the topics addressed:
- Statins & Weight Gain: We discuss concerns about the relationship between statin use and weight gain, addressing fears of indefinite use and potential side effects related to diabetes risk.
- “Normal” Lab Results Despite Symptoms: Kate questions why lab results might appear normal while still experiencing symptoms of metabolic dysfunction.
- Gut Health Impact on Metabolism: We cover the link between gut health and metabolic dysfunction, emphasizing the importance of gut motility and microbiome balance.
- Pregnancy and Metabolic Changes: Dr. Cooper discusses how pregnancy can impact metabolic function, with some women experiencing improvements while others may face challenges like gestational diabetes.
- Genetics: Dr. Emily Cooper delves into how metabolic disorders can be transferred to offspring, noting that these issues can be triggered and amplified with each pregnancy.
- Barbara inquires about the safety of GLP1 medications given a history of papillary thyroid cancer.
Resources:
- Connect with Dr. Emily Cooper on LinkedIn.
- Connect with Mark Wright on LinkedIn.
- Connect with Andrea Taylor on Instagram.
Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.
If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.
Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/